In-person arguments resumed at the U.S. Court of Appeals for the Federal Circuit on Tuesday, with the court sounding poised to throw out a $1.2 billion judgment for a patent on a life-saving cancer treatment.

Chief Judge Kimberly Moore welcomed Orrick, Herrington & Sutcliffe partner Joshua Rosenkranz and Irell & Manella partner Morgan Chu back to Courtroom 201 at 10 a.m. “Good morning. This is very exciting for us,” Moore said. “We’re very excited to be back in person with you today.”

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]